N.P.4 01 Relationship between outcome measures assessing strength and function in children with spinal muscular atrophy (SMA) type II and III

2006 ◽  
Vol 16 (9-10) ◽  
pp. 667
Author(s):  
K.J. Krosschell ◽  
C. Scott ◽  
J.A. Maczulski ◽  
K.J. Swoboda
2021 ◽  
Vol 14 ◽  
pp. 175628642199890 ◽  
Author(s):  
Alma Osmanovic ◽  
Gresa Ranxha ◽  
Mareike Kumpe ◽  
Claudia D. Wurster ◽  
Benjamin Stolte ◽  
...  

Background: Nusinersen was the first approved disease-modifying therapy for all 5q-spinal muscular atrophy (SMA) patients regardless of age or disease severity. Its efficacy in adults has recently been demonstrated in a large cohort by motor outcome measures, which were only partially suitable to detect changes in very mildly or severely affected patients. Patient-reported outcome measures (PROs) have been suggested as a valuable addition. Here, we aimed to assess treatment satisfaction and investigate whether it may be a useful PRO to monitor SMA patients. Methods: We enrolled 91 mainly adult 5q-SMA patients treated with nusinersen in a national, multicenter, cross-sectional observational study. 21 patients underwent longitudinal follow up. Patients’ satisfaction with treatment in four dimensions (global, effectiveness, convenience, side effects) was assessed by the Treatment Satisfaction Questionnaire for Medication German version 1.4 (TSQM-1.4©) and related to clinical parameters, motor scores, and treatment duration. Results: More than 90% of SMA patients were consistently satisfied over a median treatment duration of 10 months. Highest mean scores were observed in the dimensions ‘side effects,’ ‘global satisfaction,’ and ‘effectiveness’ (93.5 ± 14.8 versus 73.1 ± 21.0 and 64.8 ± 20.6, respectively). Patients’ satisfaction with the convenience of treatment was considerably lower (43.6 ± 20.2). Interestingly, satisfaction with the effectiveness was higher in ambulatory ( p = 0.014) compared with non-ambulatory patients and directly correlated to motor outcome measures. Five non-ambulatory patients withdrew from therapy. All of them presented with a deterioration of motor outcome measures and reported dissatisfaction with treatment effectiveness and convenience. Conclusion: Most patients were satisfied with nusinersen treatment effectiveness. Less severely affected patients indicated higher satisfaction. The TSQM-1.4© helped to identify therapy non-responders, who mainly addressed dissatisfaction with effectiveness and convenience. We suggest introducing the TSQM-1.4© as an additional PRO in SMA into clinical practice.


Author(s):  
Giorgia Coratti ◽  
Marika Pane ◽  
Simona Lucibello ◽  
Maria Carmela Pera ◽  
Amy Pasternak ◽  
...  

2016 ◽  
Vol 26 (6) ◽  
pp. 1721-1731 ◽  
Author(s):  
Shih-Hsiang Chou ◽  
Gau-Tyan Lin ◽  
Po-Chih Shen ◽  
Yi-Jing Lue ◽  
Cheng-Chang Lu ◽  
...  

2019 ◽  
Vol 53 ◽  
pp. 134-137 ◽  
Author(s):  
Garrett Smith ◽  
Stephanie K. Bell ◽  
John T. Sladky ◽  
Peter B. Kang ◽  
Mehmet S. Albayram

1990 ◽  
Vol 49 (3) ◽  
pp. 296
Author(s):  
Douglas W. Kingma ◽  
Warren A. Marks ◽  
Gary B. Bobele ◽  
Daniel L. Feeback ◽  
Richard W. Leech ◽  
...  

2003 ◽  
Vol 106 (5) ◽  
pp. 441-448 ◽  
Author(s):  
S. Araki ◽  
M. Hayashi ◽  
K. Tamagawa ◽  
M. Saito ◽  
S. Kato ◽  
...  

1993 ◽  
Vol 43 (6) ◽  
pp. 380-387 ◽  
Author(s):  
L.M. Brzustowicz ◽  
C. Mérette ◽  
P.W. Kleyn ◽  
T. Lehner ◽  
L.H. Castüla ◽  
...  

2019 ◽  
Vol 42 (5) ◽  
pp. 500-508 ◽  
Author(s):  
Valentina Pucciarelli ◽  
Daniele Gibelli ◽  
Chiara Mastella ◽  
Simona Bertoli ◽  
Katia Alberti ◽  
...  

Summary Objectives The main objective of this study was to assess the three-dimensional facial characteristics of children affected by spinal muscular atrophy (SMA), a severe muscular disorder characterized by hypotonia, areflexia, weakness, and respiratory impairment. Materials/Methods Stereophotogrammetric facial scans from 22 SMA type II patients aged 2–7 years were obtained. Data were analysed using both inter-landmark distances and principal component analysis and compared with data collected from matched control subjects. Results Patients had wider transverse facial diameters, but smaller biocular width. Middle and lower anterior face heights were increased, whereas the mandibular ramus was shorter, with a reduced posterior-to-anterior face height ratio. Facial width-to-length ratio was reduced. In the sagittal plane, mandibular body length, and facial divergence were increased, whereas the gonial angles were decreased. In the horizontal plane, lower facial convexity was greater in patients, whereas mandibular convexity was smaller. Patients had smaller and down-slanted eye fissures, with a larger and more vertically developed nose. Limitations This study assessed a relatively small number of patients, due to the rare frequency of SMA type II. Conclusions/Implications SMA type II children possess peculiar facial alterations that may be due to the altered muscular activity. As feeding problems may derive also by malocclusion and masticatory muscular alterations, a detailed assessment of the craniofacial individual alterations should be considered in the standards of care of these patients.


Sign in / Sign up

Export Citation Format

Share Document